Loading...
(+)-[(18)F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls
PURPOSES: We present the first in-human brain PET imaging data of the new α4β2 nicotinic acetylcholine receptor (nAChR)–targeting radioligand (+)-[(18)F]Flubatine. Aims were to develop a kinetic modeling-based approach to quantify (+)-[(18)F]Flubatine and compare the data of healthy controls (HCs) a...
Na minha lista:
| Udgivet i: | Eur J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036219/ https://ncbi.nlm.nih.gov/pubmed/32935187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-05029-w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|